Your session is about to expire
← Back to Search
ECG Device
Atrial Fibrillation for Atrial Fibrillation
N/A
Recruiting
Led By Elaine WAN, MD
Research Sponsored by Withings
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
Study Summary
This trialtests a heart monitor app to detect atrial fibrillation, a type of irregular heartbeat.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Co-
Secondary outcome measures
Clinical Equivalence of ECG waveforms
Evaluation of the classification into heart rate subgroups
Heart Rate equivalence
Trial Design
2Treatment groups
Experimental Treatment
Group I: Normal Sinus RhythmExperimental Treatment1 Intervention
Group II: Atrial FibrillationExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
WithingsLead Sponsor
19 Previous Clinical Trials
3,930 Total Patients Enrolled
7 Trials studying Atrial Fibrillation
1,941 Patients Enrolled for Atrial Fibrillation
SyntactxNETWORK
22 Previous Clinical Trials
1,146,736 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
632 Patients Enrolled for Atrial Fibrillation
Elaine WAN, MDPrincipal InvestigatorColumbia University Irving Medical Center/ NewYork Presbyterian Hospital
1 Previous Clinical Trials
632 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
632 Patients Enrolled for Atrial Fibrillation
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger